MedPath

浙江天瑞药业有限公司

Ownership
-
Established
1986-12-31
Employees
-
Market Cap
-
Website
http://www.zjtr.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

116

NMPA:116

Drug Approvals

Lincomycin Hydrochloride Injection

Product Name
盐酸林可霉素注射液
Approval Number
国药准字H33022237
Approval Date
Sep 25, 2024
NMPA

Iohexol Injection

Product Name
碘海醇注射液
Approval Number
国药准字H20103185
Approval Date
Sep 20, 2024
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H33020673
Approval Date
Sep 20, 2024
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H20055031
Approval Date
Sep 20, 2024
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H33020668
Approval Date
Sep 20, 2024
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H33020670
Approval Date
Sep 20, 2024
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H33020667
Approval Date
Sep 20, 2024
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H33020669
Approval Date
Sep 20, 2024
NMPA

Iohexol Injection

Product Name
碘海醇注射液
Approval Number
国药准字H20103186
Approval Date
Sep 20, 2024
NMPA

Sodium Chloride Physiological Solution

Product Name
生理氯化钠溶液
Approval Number
国药准字H20073148
Approval Date
Sep 14, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 12
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.